# Celox™ PPH for Reaching Haemostasis in Patients With Postpartum Hemorrhage

> **NCT06033170** · NA · UNKNOWN · sponsor: **Medtrade** · enrollment: 96 (estimated)

## Conditions studied

- Postpartum Hemorrhage

## Interventions

- **DEVICE:** CELOX™ PPH

## Key facts

- **NCT ID:** NCT06033170
- **Lead sponsor:** Medtrade
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09
- **Primary completion:** 2024-09
- **Final completion:** 2025-10
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2023-09-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06033170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06033170, "Celox™ PPH for Reaching Haemostasis in Patients With Postpartum Hemorrhage". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06033170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*